PCM
XBI icon

Presidio Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Presidio Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
1,812
+64
+4% +$8.65K 0.07% 65
2026
Q1 		$223K Sell
1,748
-270
-13% -$33.7K 0.06% 66
2025
Q4 		$246K Buy
+2,018
New +$231K 0.07% 61

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Presidio Capital Management's XBI Position: Q2 2026 in Review

Presidio Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.7% in Q2 2026, buying an estimated $8.65K and bringing the position to 1,812 shares worth $287K. The position accounts for 0.07% of the portfolio, ranked #65.

Presidio Capital Management first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 368 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Presidio Capital Management held 1,812 shares of State Street SPDR S&P Biotech ETF worth $287K as of Q2 2026.
  • Presidio Capital Management bought 64 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.65K.
  • State Street SPDR S&P Biotech ETF made up 0.07% of Presidio Capital Management's portfolio in Q2 2026, its #65 holding.
  • Presidio Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 368 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Presidio Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.